Update date
31 Dec 2021
Shareable Research Card
Gamida Cell Ltd. Cash and Cash Equivalents, Period Increase (Decrease)
This metric view shows Gamida Cell Ltd. cash and cash equivalents, period increase (decrease) history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2021
- Latest reported value
- $71,278,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2021
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2021.
- Latest reported value on this page: $71,278,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Cash and Cash Equivalents, Period Increase (Decrease)
Latest reported cash and cash equivalents, period increase (decrease): $71,278,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2021
SEC-backed company facts were refreshed from filings filed on 23 May 2024.
Benchmark Context
How Cash and Cash Equivalents, Period Increase (Decrease) compares with peers
Gamida Cell Ltd. is outside the visible top 120 companies for cash and cash equivalents, period increase (decrease) in the current sample.
Compared with
Compared with 120 companies reporting cash and cash equivalents, period increase (decrease) in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about -0.1x the current sample midpoint. Cash and Cash Equivalents, Period Increase (Decrease) is down about 184% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2010 to 31 Mar 2022.
- Nearby companies in this sample: AT&T INC. and AbbVie Inc..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Gamida Cell Ltd.: Cash and Cash Equivalents, Period Increase (Decrease)
Latest period: 2021. Period end: 31 Dec 2021. Units: USD. Frequency: annual.
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
Metric Snapshot
- Latest value
- $71,278,000
- Coverage range
- 31 Dec 2020 - 31 Dec 2021
- Fact rows
- 2
What This Metric Tells You
- Shows the reported level of cash and cash equivalents, period increase (decrease) over 31 Dec 2020 - 31 Dec 2021.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 2 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Cash and Cash Equivalents, Period Increase (Decrease) levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | AT&T INC. (t) | $44,710,000,000 | Year - 31 Dec 2017 | Open AT&T INC. Cash and Cash Equivalents, Period Increase (Decrease) |
| 2 | AbbVie Inc. (abbv) | $32,635,000,000 | Year - 31 Dec 2019 | Open AbbVie Inc. Cash and Cash Equivalents, Period Increase (Decrease) |
| 3 | BANK OF AMERICA CORP /DE/ (bac) | $19,970,000,000 | Year - 31 Dec 2018 | Open BANK OF AMERICA CORP /DE/ Cash and Cash Equivalents, Period Increase (Decrease) |
| 4 | DANAHER CORP /DE/ (dhr) | $19,124,500,000 | Year - 31 Dec 2019 | Open DANAHER CORP /DE/ Cash and Cash Equivalents, Period Increase (Decrease) |
| 5 | Apple Inc. (aapl) | $18,858,000,000 | Quarter - 29 Dec 2018 | Open Apple Inc. Cash and Cash Equivalents, Period Increase (Decrease) |
| 6 | Alibaba Group Holding Ltd (baba) | $8,860,000,000 | Year - 31 Mar 2018 | Open Alibaba Group Holding Ltd Cash and Cash Equivalents, Period Increase (Decrease) |
Metric Details
- Metric
- Cash and Cash Equivalents, Period Increase (Decrease) (CashAndCashEquivalentsPeriodIncreaseDecrease)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- annual
- History range
- 31 Dec 2020 - 31 Dec 2021
- Facts on this page
- 2
- Description
- Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Cash and Cash Equivalents, Period Increase (Decrease), Annual (USD)
Cash and Cash Equivalents, Period Increase (Decrease), YoY Annual Change (%)
Gamida Cell Ltd. Annual Cash and Cash Equivalents, Period Increase (Decrease) (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2021 | $71,278,000 | -$156,610,000 | -184% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 24 Mar 2022 | 2021 | FY |
| 2020 | $85,332,000 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 24 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.